Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

Last updated: January 22, 2021
Sponsor: Rothman Institute Orthopaedics
Overall Status: Active - Enrolling

Phase

3

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04725357
JHOR20D.1216
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18
  • Scheduled for arthroscopic labrum repair of the shoulder

Exclusion

Exclusion Criteria:

  • History of opioid, acetaminophen, NSAID or local anesthetic allergy or intolerance, orcontraindications to these medications.
  • Currently on long-term preoperative narcotics
  • Scheduled for revision arthroscopic repairs of the shoulder
  • Unable/unwilling to consent for enrollment
  • Unable to complete postoperative surveys
  • History of chronic pain syndromes (fibromyalgia, chronic diffuse MSK pain, etc)
  • Patients under the age of 18
  • Pregnant or breastfeeding women
  • Scheduled for concurrent procedures

Study Design

Total Participants: 96
Study Start date:
January 25, 2021
Estimated Completion Date:
January 25, 2022

Connect with a study center

  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvania 19107
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.